Oxidative stress induces a prolonged but reversible arrest in p53-null cancer cells, involving a Chk1-dependent G2 checkpoint
Open Access
- 1 May 2006
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 25 (45) , 6037-6047
- https://doi.org/10.1038/sj.onc.1209629
Abstract
Reactive oxygen species (ROS), the principal mediators of oxidative stress, induce responses such as apoptosis or permanent growth arrest/senescence in normal cells. Moreover, p53 activation itself contributes to ROS accumulation. Here we show that treatment of p53-null cancer cells with sublethal concentrations of ROS triggered an arrest with some morphological similarities to cellular senescence. Different from a classical senescent arrest in G1, the ROS-induced arrest was predominantly in the G2 phase of the cell cycle, and its establishment depended at least in part on an intact Chk1-dependent checkpoint. Chk1 remained phosphorylated only during the repair of double strand DNA breaks, after which Chk1 was inactivated, the G2 arrest was suppressed, and some cells recovered their ability to proliferate. Inhibition of Chk1 by an RNAi approach resulted in an increase in cell death in p53-null cells, showing that the Chk1-dependent G2 checkpoint protected cells that lacked a functional p53 pathway from oxidative stress. It has been proposed that the induction of a senescent-like phenotype by antineoplastic agents can contribute therapeutic efficacy. Our results indicate that oxidative stress-induced growth arrest of p53-null tumor cells cannot be equated with effective therapy owing to its reversibility and supports the concept that targeting Chk1 may enhance the effects of DNA-damaging agents on cancer progression in such tumors.Keywords
This publication has 75 references indexed in Scilit:
- Molecular signature of oncogenic ras-induced senescenceOncogene, 2004
- Gene expression and regulation in H2O2-induced premature senescence of human foreskin fibroblasts expressing or not telomeraseExperimental Gerontology, 2004
- The emerging role of reactive oxygen species in cancer therapyEuropean Journal Of Cancer, 2004
- Cell death by mitotic catastrophe: a molecular definitionOncogene, 2004
- The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer CellsPublished by Elsevier ,2003
- AcknowledgementDrugs, 2003
- The Broad Spectrum of Responses to Oxidants in Proliferating Cells: A New Paradigm for Oxidative StressIUBMB Life, 1999
- Cell cycle-dependent and ATM-independent expression of human Chk1 kinaseOncogene, 1999
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Low-Level Oxidative Stress Causes Cell Cycle-Specific Arrest in Cultured CellsBiochemical and Biophysical Research Communications, 1995